New Hampshire Medicaid and GLP-1s
New Hampshire Medicaid stopped paying for GLP-1s prescribed only for weight loss on January 1, 2026. The plans that administer the benefit told their members and providers in October 2025, and they name the conditions that keep coverage. One wrinkle worth stating plainly: we could not verify the state agency's own site, so what follows comes from the plans' paperwork.
What changed, and what the document says
| Point | Status | What the source says |
|---|---|---|
| GLP-1s for weight loss | Not covered | Not covered from January 1, 2026, when weight loss is the only reason for the prescription.
AmeriHealth Caritas New Hampshire — notice to Medicaid providers — October 10, 2025 |
| What keeps coverage | Covered | Four conditions, named. If one of them is on the chart, the drug is still paid for.
AmeriHealth Caritas New Hampshire — notice to Medicaid providers — October 10, 2025 |
| Which drugs | Context | Saxenda, Wegovy and Zepbound by name, and generics of them.
AmeriHealth Caritas New Hampshire — notice to Medicaid providers — October 10, 2025 |
| A second plan says the same | Context | A different managed-care plan told its members the same thing four days later. Two independent notices, one change.
NH Healthy Families — member newsroom notice — 10/14/25 |
| The national picture | Context | New Hampshire is one of four states a national tracker names as having ended this coverage since October 2025.
KFF — Jan 16, 2026 |
Which of these companies serve New Hampshire?
Of the 28 companies we grade, 4 publish a list of the states they are licensed in. We checked 23 more and found no such list on any page we read; 1 we have not checked either way.
3 of those lists name New Hampshire: Gala Health, Care Bare Rx and Vita Bella. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. These are the graded reviews worth reading first from here:
- Alan MedsPublishes a real month-to-month semaglutide price, which is rarer than it sounds — though its tirzepatide figure assumes a six-month prepay.
- LifeMDIts $149 headline leaves out a separate $149 monthly program fee that its own FAQ calls mandatory.
- Mochi HealthSays terms vary by state but publishes no state list, so a New Hampshire shopper can't confirm what applies.
Our grading method and how we verify a price explain what those letters mean.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- Change in Medicaid Coverage for GLP Medications — AmeriHealth Caritas New Hampshire — notice to Medicaid providers. the "Date:" field in the notice header: October 10, 2025.
- GLP-1 Medications Change in Coverage Effective January 1, 2026 — NH Healthy Families — member newsroom notice. the "Date:" field on the notice, printed in that format: 10/14/25.
- Medicaid Coverage of and Spending on GLP-1s — KFF. Published, as printed beside the author's name: Jan 16, 2026.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.